Summary: Song and colleagues describe how N-glycans stabilize expression of checkpoint molecule B7-H4 that suppresses T-cell function. Inhibiting N-glycan stabilization of B7-H4 generates an immune hot cancer that is more responsive to combination therapies. See related article by Song et al., [p. 1872][1] . [1]: /lookup/volpage/10/1872?iss=12